Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Centrexion Therapeutics Acquires Three New Analgesic Candidates from Boehringer Ingelheim 11
Venture Financing 13
Centrexion Therapeutics Raises USD67 Million in Series D Financing 13
Centrexion Therapeutics Raises USD5.3 Million in Venture Financing 15
Centrexion Therapeutics Raises USD16.6 Million in Venture Financing 16
Centrexion Therapeutics Raises USD11.1 Million in Financing Round 17
Centrexion Therapeutics Raises USD7 Million in Venture Financing 18
Centrexion Raises USD14.7 Million in Venture Financing 19
Centrexion Therapeutics Raises USD8.8 Million in Financing Round 20
Debt Offering 21
Centrexion Therapeutics Raises USD10.5 Million Private Placement of Notes 21
Centrexion Therapeutics Corp – Key Competitors 22
Centrexion Therapeutics Corp – Key Employees 23
Centrexion Therapeutics Corp – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Aug 15, 2018: Centrexion Therapeutics names Dan Mendelson as Board Director 25
Jul 30, 2018: Centrexion Therapeutics names Nick Harvey as chief financial officer 26
Jun 26, 2018: Centrexion Therapeutics Names Joseph R. Swedish As Board Director 27
Jun 26, 2017: Centrexion Therapeutics Names Shawn Tomasello to its Board of Directors 28
Product News 29
08/29/2017: Centrexion Therapeutics to Present 6-Month Efficacy Data on CNTX-4975 for the Treatment of Chronic Pain Associated with Knee Osteoarthritis at PAINWeek 2017 29
06/07/2017: Centrexion Therapeutics Announces Oral Presentation of Six Month Efficacy Data on CNTX-4975 for the Treatment of Chronic Pain Associated with Knee Osteoarthritis at the Annual European Congress of Rheumatology 30
05/10/2017: Centrexion Therapeutics to Present Data on CNTX-4975 for the Treatment of Chronic Pain Associated with Morton’s Neuroma and Knee Osteoarthritis at American Pain Society 2017 Annual Scientific Meeting 31
Product Approvals 32
Jan 16, 2018: Centrexion Therapeutics Announces Fast Track Designation Granted by FDA to CNTX-4975 for Treatment of Knee Osteoarthritis Pain 32
Clinical Trials 33
Jan 02, 2018: Centrexion Therapeutics Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018 33
Oct 30, 2017: Centrexion Therapeutics Announces Multiple Data Presentations on CNTX-4975 at the American College of Rheumatology Annual Meeting 2017 34
Sep 26, 2017: Centrexion Therapeutics to Present Phase 2b data of Osteoarthritis Drug Candidate CNTX-4975 at the 11th Annual Pain and Migraine Therapeutics Summit 35
Jul 20, 2017: Centrexion Therapeutics to Present Phase 2b Data on CNTX-4975 for the Treatment of Chronic Pain Associated with Morton’s Neuroma at the American Podiatric Medical Association 2017 Annual Scientific Meeting 36
Jun 13, 2017: Centrexion Therapeutics Announces New 6-Month Data Demonstrating Significant and Durable Pain Relief with CNTX-4975 for Treatment of Moderate to Severe Knee Osteoarthritis Pain 37
May 25, 2017: Centrexion Therapeutics to Present Data on CNTX-4975 for the Treatment of Chronic Pain Associated with Knee Osteoarthritis at European Federation of National Associations of Orthopaedics and Traumatologys 2017 Annual Congress 39
Mar 23, 2017: Centrexion Therapeutics to Present Data on CNTX-4975 from the Treatment of Knee Osteoarthritis Pain at IX SIMPAR-ISURA 40
Mar 16, 2017: Centrexion Therapeutics to Present Late-Breaking Poster at the 33rd Annual American Academy of Pain Medicine Meeting 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts 2
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Centrexion Therapeutics Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centrexion Therapeutics Acquires Three New Analgesic Candidates from Boehringer Ingelheim 11
Centrexion Therapeutics Raises USD67 Million in Series D Financing 13
Centrexion Therapeutics Raises USD5.3 Million in Venture Financing 15
Centrexion Therapeutics Raises USD16.6 Million in Venture Financing 16
Centrexion Therapeutics Raises USD11.1 Million in Financing Round 17
Centrexion Therapeutics Raises USD7 Million in Venture Financing 18
Centrexion Raises USD14.7 Million in Venture Financing 19
Centrexion Therapeutics Raises USD8.8 Million in Financing Round 20
Centrexion Therapeutics Raises USD10.5 Million Private Placement of Notes 21
Centrexion Therapeutics Corp, Key Competitors 22
Centrexion Therapeutics Corp, Key Employees 23
List of Figures
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Centrexion Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9